
Congenital diaphragmatic hernia (CDH) is often detectable prenatally. Advances in genetic testing have made it possible to obtain a molecular diagnosis in many fetuses with CDH. Here, the study reviews the aneuploidies, copy number variants (CNVs), and single genes that have been associated with CDH. The present study suggested that array‐based CNV analysis, with or without a chromosome analysis, is the optimal test for identifying chromosomal abnormalities and CNVs in fetuses with CDH. Whole-exome sequencing (WES) is the most comprehensive strategy currently available to identify causative sequence variants. Whole-genome sequencing (WGS) with CNV analysis has the potential to become the most efficient and effective means of identifying an underlying diagnosis but is not yet routinely available for prenatal diagnosis. The study describes how to overcome and address the diagnostic and clinical uncertainty that may remain after genetic testing and review how a molecular diagnosis may impact recurrence risk estimations, mortality rates, and the availability and outcomes of fetal therapy. The present study concludes that after the prenatal detection of CDH, patients should be counselled about the possible genetic causes of the CDH, and the genetic testing modalities available to them, by generally accepted guidelines for pretest counselling in the prenatal setting.
Like
Save
Share